USD 0.02
(-1.41%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 90.38 Thousand CAD | -18.24% |
2022 | 110.55 Thousand CAD | 176.38% |
2021 | 40 Thousand CAD | -58.31% |
2020 | 95.93 Thousand CAD | 10.32% |
2019 | 86.96 Thousand CAD | -55.52% |
2018 | 195.51 Thousand CAD | -27.69% |
2017 | 270.39 Thousand CAD | -65.09% |
2016 | 774.54 Thousand CAD | 5.56% |
2015 | 733.72 Thousand CAD | -84.4% |
2014 | 4.7 Million CAD | 17.27% |
2013 | 4.01 Million CAD | 17.31% |
2012 | 3.41 Million CAD | 16.05% |
2011 | 2.94 Million CAD | 0.0% |
2009 | 2.17 Million CAD | 15.41% |
2008 | 1.88 Million CAD | 21.22% |
2007 | 1.55 Million CAD | 36.14% |
2006 | 1.14 Million CAD | 121.88% |
2005 | 515.14 Thousand CAD | 0.0% |
2004 | - CAD | -100.0% |
2003 | 36 Thousand CAD | 0.0% |
2002 | - CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 78.59 Thousand CAD | -7.16% |
2024 Q1 | 84.65 Thousand CAD | -6.35% |
2024 Q3 | 72.14 Thousand CAD | -8.2% |
2023 Q1 | 105.94 Thousand CAD | -4.17% |
2023 Q3 | 95.82 Thousand CAD | -5.2% |
2023 Q4 | 90.38 Thousand CAD | -5.67% |
2023 Q2 | 101.07 Thousand CAD | -4.6% |
2023 FY | 90.38 Thousand CAD | -18.24% |
2022 Q1 | 40 Thousand CAD | 0.0% |
2022 FY | 110.55 Thousand CAD | 176.38% |
2022 Q4 | 110.55 Thousand CAD | 176.38% |
2022 Q2 | 40 Thousand CAD | 0.0% |
2022 Q3 | 40 Thousand CAD | 0.0% |
2021 Q1 | 46.61 Thousand CAD | -51.41% |
2021 Q4 | 40 Thousand CAD | -23.28% |
2021 Q3 | 52.14 Thousand CAD | -5.44% |
2021 Q2 | 55.14 Thousand CAD | 18.29% |
2021 FY | 40 Thousand CAD | -58.31% |
2020 Q2 | 156.51 Thousand CAD | 71.56% |
2020 Q3 | 232.4 Thousand CAD | 48.49% |
2020 FY | 95.93 Thousand CAD | 10.32% |
2020 Q4 | 95.93 Thousand CAD | -58.72% |
2020 Q1 | 91.23 Thousand CAD | 4.9% |
2019 Q1 | 85.48 Thousand CAD | -56.28% |
2019 Q2 | 92.83 Thousand CAD | 8.6% |
2019 Q3 | 94.93 Thousand CAD | 2.27% |
2019 Q4 | 86.96 Thousand CAD | -8.4% |
2019 FY | 86.96 Thousand CAD | -55.52% |
2018 FY | 195.51 Thousand CAD | -27.69% |
2018 Q1 | 275.25 Thousand CAD | 1.8% |
2018 Q3 | 223.92 Thousand CAD | 611.62% |
2018 Q2 | 31.46 Thousand CAD | -88.57% |
2018 Q4 | 195.51 Thousand CAD | -12.69% |
2017 FY | 270.39 Thousand CAD | -65.09% |
2017 Q2 | 799.11 Thousand CAD | 2.86% |
2017 Q3 | 402.34 Thousand CAD | -49.65% |
2017 Q4 | 270.39 Thousand CAD | -32.79% |
2017 Q1 | 776.92 Thousand CAD | 0.31% |
2016 FY | 774.54 Thousand CAD | 5.56% |
2016 Q1 | 748.09 Thousand CAD | 1.96% |
2016 Q3 | 766.59 Thousand CAD | 0.16% |
2016 Q2 | 765.36 Thousand CAD | 2.31% |
2016 Q4 | 774.54 Thousand CAD | 1.04% |
2015 Q2 | 727.91 Thousand CAD | -85.1% |
2015 Q4 | 733.72 Thousand CAD | 0.44% |
2015 FY | 733.72 Thousand CAD | -84.4% |
2015 Q1 | 4.88 Million CAD | 3.85% |
2015 Q3 | 730.49 Thousand CAD | 0.35% |
2014 Q4 | 4.7 Million CAD | 4.38% |
2014 Q2 | 4.34 Million CAD | 4.34% |
2014 Q1 | 4.16 Million CAD | 3.81% |
2014 Q3 | 4.5 Million CAD | 3.72% |
2014 FY | 4.7 Million CAD | 17.27% |
2013 Q4 | 4.01 Million CAD | 3.81% |
2013 Q2 | 3.72 Million CAD | 4.84% |
2013 Q1 | 3.55 Million CAD | 3.83% |
2013 FY | 4.01 Million CAD | 17.31% |
2013 Q3 | 3.86 Million CAD | 3.81% |
2012 Q4 | 3.41 Million CAD | 0.0% |
2012 FY | 3.41 Million CAD | 16.05% |
2011 FY | 2.94 Million CAD | 0.0% |
2010 Q2 | 2.33 Million CAD | 3.47% |
2010 Q3 | 2.4 Million CAD | 3.27% |
2010 Q1 | 2.25 Million CAD | 3.59% |
2009 FY | 2.17 Million CAD | 15.41% |
2009 Q4 | 2.17 Million CAD | -42.33% |
2009 Q1 | 1.95 Million CAD | 3.63% |
2009 Q3 | 3.77 Million CAD | 4.68% |
2009 Q2 | 3.6 Million CAD | 84.47% |
2008 Q2 | 1.75 Million CAD | 8.14% |
2008 FY | 1.88 Million CAD | 21.22% |
2008 Q4 | 1.88 Million CAD | 3.67% |
2008 Q3 | 1.81 Million CAD | 3.63% |
2008 Q1 | 1.62 Million CAD | 4.33% |
2007 Q1 | 1.24 Million CAD | 9.01% |
2007 Q2 | 1.35 Million CAD | 8.4% |
2007 FY | 1.55 Million CAD | 36.14% |
2007 Q3 | 1.45 Million CAD | 7.56% |
2007 Q4 | 1.55 Million CAD | 7.1% |
2006 Q4 | 1.14 Million CAD | -11.42% |
2006 Q3 | 1.29 Million CAD | 4.39% |
2006 FY | 1.14 Million CAD | 121.88% |
2006 Q2 | 1.23 Million CAD | 131.1% |
2006 Q1 | 534.86 Thousand CAD | 3.83% |
2005 FY | 515.14 Thousand CAD | 0.0% |
2005 Q3 | - CAD | 0.0% |
2005 Q1 | - CAD | 0.0% |
2005 Q2 | - CAD | 0.0% |
2005 Q4 | 515.14 Thousand CAD | 0.0% |
2004 Q2 | 28 Thousand CAD | 0.0% |
2004 FY | - CAD | -100.0% |
2004 Q1 | 28 Thousand CAD | 0.0% |
2004 Q3 | - CAD | -100.0% |
2003 FY | 36 Thousand CAD | 0.0% |
2003 Q1 | 36 Thousand CAD | -14.29% |
2003 Q4 | 28 Thousand CAD | -6.67% |
2003 Q3 | 30 Thousand CAD | 0.0% |
2003 Q2 | 30 Thousand CAD | -16.67% |
2002 FY | - CAD | 0.0% |
2002 Q3 | 283.27 Thousand CAD | -9.76% |
2002 Q4 | 42 Thousand CAD | -85.17% |
2002 Q2 | 313.9 Thousand CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Manhattan Scientifics, Inc. | 60 Thousand USD | -50.647% |
Össur hf. | 467.73 Million USD | 99.981% |
QHSLab, Inc. | 1.78 Million USD | 94.926% |
Wellstar International, Inc. | 51.36 Million USD | 99.824% |
Össur hf. | 467.73 Million USD | 99.981% |
Bionovate Technologies Corp | - USD | -Infinity% |
Escalon Medical Corp. | 524.71 Thousand USD | 82.774% |
Aurora Spine Corporation | 2.67 Million USD | 96.615% |
BrainsWay Ltd. | 471 Thousand USD | 80.809% |
Lattice Biologics Ltd. | - USD | -Infinity% |
AVITA Medical, Inc. | 449.48 Thousand USD | 79.891% |
CVR Medical Corp. | - USD | -Infinity% |
Hamilton Thorne Ltd. | 27.81 Million USD | 99.675% |
BioElectronics Corporation | 14.83 Million USD | 99.391% |
Vivos Inc. | - USD | -Infinity% |
Kelyniam Global, Inc. | 496.39 Thousand USD | 81.791% |
Zecotek Photonics Inc. | 3.22 Million USD | 97.195% |
REMSleep Holdings, Inc. | 178.11 Thousand USD | 49.253% |
EKF Diagnostics Holdings plc | 5.21 Million USD | 98.268% |
Avitar, Inc. | 5.26 Million USD | 98.283% |
Nanomix Corporation | 11.4 Million USD | 99.208% |
Theraclion SA | 1.95 Million EUR | 95.366% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 4.04 Million USD | 97.764% |
NewCardio, Inc. | 3 Million USD | 96.987% |
Positron Corporation | 1.78 Million USD | 94.943% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 1.69 Million USD | 94.679% |
Lombard Medical, Inc. | 32.29 Million USD | 99.72% |
ALR Technologies Inc. | 19.26 Million USD | 99.531% |
Stratec SE | 156.16 Million USD | 99.942% |
Vycor Medical, Inc. | 1.11 Million USD | 91.859% |
Heart Tronics, Inc. | 209.28 Thousand USD | 56.811% |
Nu-Med Plus, Inc. | 100 Thousand USD | 9.612% |
MicroPort Scientific Corporation | 1.69 Billion USD | 99.995% |
VMS Rehab Systems, Inc. | 133.52 USD | -67596.225% |
Guided Therapeutics, Inc. | 2.05 Million USD | 95.608% |
Ingen Technologies, Inc. | 631.15 Thousand USD | 85.679% |
CYduct Diagnostics, Inc. | 670 Thousand USD | 86.509% |
Odyssey Group International, Inc. | 2.14 Million USD | 95.785% |
SANUWAVE Health, Inc. | 31.94 Million USD | 99.717% |
IR-Med Inc. | 161 Thousand USD | 43.858% |
Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | 53.141% |
United American Healthcare Corporation | - USD | -Infinity% |
Polarean Imaging plc | 216.38 Thousand USD | 58.228% |
ECGI Holdings, Inc. | 3.17 Million USD | 97.15% |
Capital Group Holdings, Inc. | 4944.00 USD | -1728.236% |
ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 88.697% |
Medical Supply International USA, Inc. | 227 Thousand USD | 60.182% |
Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 97.64% |
Nexeon MedSystems Inc. | 4.21 Million USD | 97.856% |
SS Innovations International, Inc. | 8.21 Million USD | 98.9% |
Urologix, Inc. | 5.33 Million USD | 98.305% |
Qualis Innovations, Inc. | 9102.00 USD | -893.056% |
Smith & Nephew plc | 3.07 Billion USD | 99.997% |
NIOX Group Plc | 1.4 Million USD | 93.545% |
Fuse Medical, Inc. | 1.99 Million USD | 95.466% |
Broncus Holding Corporation | 2.35 Million USD | 96.161% |
Brain Scientific Inc. | 2.86 Million USD | 96.843% |
Pressure BioSciences, Inc. | 22.75 Million USD | 99.603% |
Health Logic Interactive Inc. | 40.44 Thousand USD | -123.5% |